Provided by Tiger Fintech (Singapore) Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.9100
-0.0188-2.02%
Volume:187.14K
Turnover:165.65K
Market Cap:2.76M
PE:-0.03
High:0.9265
Open:0.9009
Low:0.8200
Close:0.9288
Loading ...

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga
·
18 Dec 2024

CERo Therapeutics Names Chris Ehrlich as Permanent CEO; Shares Slump

MT Newswires Live
·
06 Dec 2024

Cero Therapeutics appoints Chris Ehrlich as CEO

TIPRANKS
·
06 Dec 2024

Cero Therapeutics, Inc. Appoints Chris Ehrlich CEO

THOMSON REUTERS
·
06 Dec 2024

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

GlobeNewswire
·
06 Dec 2024

Cero Therapeutics files to sell 210M shares of common stock for holders

TIPRANKS
·
27 Nov 2024

Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners

THOMSON REUTERS
·
27 Nov 2024

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live
·
16 Nov 2024

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live
·
16 Nov 2024

CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar

MT Newswires Live
·
15 Nov 2024

Cero Therapeutics receives FDA clearance of IND application for CER-1236

TIPRANKS
·
15 Nov 2024

Cero Therapeutics Holdings Inc - to Initiate Phase 1 Trials for Cer-1236 in Early 2025

THOMSON REUTERS
·
15 Nov 2024

Cero Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound Cer-1236 in Acute Myelogenous Leukemia

THOMSON REUTERS
·
15 Nov 2024

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

GlobeNewswire
·
15 Nov 2024

Cero Therapeutics Officer YK Bioventures Opportunities GP I, LLC Sold 3,250,000 Shares

SEC Track
·
15 Nov 2024

CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data

TIPRANKS
·
12 Nov 2024